Vimarsana
Biggest News Aggregation in the World

Page 12 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer - Vimarsana News

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer

PRINCETON, N.J., July 19, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its...

DCS joins Odyssey to support the Air Force Life Cycle Management Center Digital Directorate (AFLCMC/HB) - Vimarsana News

DCS joins Odyssey to support the Air Force Life Cycle Management Center Digital Directorate (AFLCMC/HB)

/PRNewswire/ -- DCS Corporation has been awarded a subcontract by Odyssey Systems Consulting Group, Ltd. to support the Air Force Life Cycle Management Center...

CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease - Vimarsana News

CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease

PRINCETON, N.J., July 11, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its...

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - Vimarsana News

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial

PRINCETON, N.J., July 07, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its...

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - CytoSorbents (NASDAQ:CTSO) - Vimarsana News

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial - CytoSorbents (NASDAQ:CTSO)

PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its